examined 10 astronauts who were prescribed 70 mg of alendronate weekly, commencing 3 wk prior to a 5.5-mo ISS expedition and continuing throughout.
25
Astronauts were required to undertake the normal 2.5-h daily exercise regime during the study.
BMD at the femoral neck, trochanter, total hip, pelvis, and lumbar spine was assessed pre- and postflight using dual-energy X-ray absorption (DXA) and quantitative computed tomography (QCT). Markers of bone turnover, including urinary and serum calcium, NTX, CTX, Vitamin D, and PTH, were recorded at specified intervals pre